Compounds > verapamil

verapamil and glycylsarcosine

verapamil has been researched along with glycylsarcosine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nezu, JI; Ohashi, R; Oku, A; Sai, Y; Shimane, M; Tamai, I; Tsuji, A; Yabuuchi, H1
Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K1
Luo, G; Schiller, PW; Szeto, HH; Zhao, GM; Zhao, K1
Kato, Y; Kubo, Y; Sugiura, T; Tsuji, A1

Reviews

1 review(s) available for verapamil and glycylsarcosine

ArticleYear
Membrane transporters in drug development.
    Nature reviews. Drug discovery, 2010, Volume: 9, Issue:3

    Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs

2010

Other Studies

4 other study(ies) available for verapamil and glycylsarcosine

ArticleYear
Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 291, Issue:2

    Topics: Biological Transport, Active; Carnitine; Carrier Proteins; Cations; Cells, Cultured; Dose-Response Relationship, Drug; Embryo, Mammalian; Humans; Hydrogen-Ion Concentration; Kidney; Membrane Proteins; Organic Cation Transport Proteins; Sodium; Solute Carrier Family 22 Member 5; Stereoisomerism

1999
QSAR-based permeability model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8

    Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2011
Transcellular transport of a highly polar 3+ net charge opioid tetrapeptide.
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 304, Issue:1

    Topics: Biological Transport, Active; Blood-Brain Barrier; Caco-2 Cells; Calcium Channel Blockers; Carrier Proteins; Cell Membrane; Diethyl Pyrocarbonate; Dipeptides; Energy Metabolism; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Microscopy, Confocal; Oligopeptides; Opioid Peptides; Peptide Transporter 1; Radioligand Assay; Symporters; Verapamil

2003
Mutation in an adaptor protein PDZK1 affects transport activity of organic cation transporter OCTNs and oligopeptide transporter PEPT2.
    Drug metabolism and pharmacokinetics, 2006, Volume: 21, Issue:5

    Topics: Adaptor Protein Complex gamma Subunits; Biological Transport; Carbon Radioisotopes; Carnitine; Carrier Proteins; Cell Line; Cell Membrane; Dipeptides; Humans; Membrane Proteins; Mutation; Organic Cation Transport Proteins; Organic Cation Transporter 1; Protein Binding; Pyrilamine; Solute Carrier Family 22 Member 5; Symporters; Tetraethylammonium; Transfection; Tritium; Two-Hybrid System Techniques; Verapamil

2006